-
-
The relationship between uric acid (URA) and cardiovascular (CV) risk has been the subject of controversy for decades.
-
The FDA has approved a new, highly selective alpha-1 adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia (BPH).
-
The American College of Physicians has just published a new clinical practice guideline on the use of second-generation antidepressants in treating depressive disorders.
-
The syllogistic process that led us all to accept the utility of ASA in prevention of CVD in diabetics seemed innocent enough: a) ASA reduces CV events in persons with CVD, and b) diabetes is considered a CV risk equivalent; therefore, c) ASA must reduce CV events in persons with diabetes.
-
Massage is one of the most commonly used non-pharmacological interventions for managing cancer pain.
-
Healthy middle-aged men and women with normal LDL-cholesterol levels and elevated levels of the inflammatory biomarker high-sensitivity C-reactive protein (hsCRP) show significant decreases in clinical cardiovascular events when treated with rosuvastatin vs placebo.
-
A well-regarded, standardized extract of Ginkgo biloba does not appear to help prevent development of dementia in seniors with baseline normal or mildly impaired cognitive function. Whether use of ginkgo earlier in life has a primary preventive effect on development of dementia remains to be determined.
-
Probiotics are often thought of as concentrated yogurt capsules, most useful for the prevention or treatment of antibiotic-induced diarrhea. Recent evidence, though, is starting to point to a much greater use for the provision of "good bacteria" to the gastrointestinal tract.
-